⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1042812 | 0.84 | — | — | |
| SCHEMBL31084279 | 0.80 | CYP3A4 (0.32) | — | |
| Hydrazine SCHEMBL28121587 | 0.80 | — | — | |
| Chloroform SCHEMBL27610928 | 0.77 | — | — | |
| SCHEMBL34472342 | 0.75 | — | — | |
| Piperazine SCHEMBL27841791 | 0.75 | — | — | |
| SCHEMBL27868729 | 0.73 | — | — | |
| Pyrrolidine SCHEMBL28229892 | 0.72 | — | — | |
| SCHEMBL1101400 | 0.69 | — | — | |
| SCHEMBL17770589 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4491624-A1 | HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEIN | Astellas Pharma Inc. (JP) | 2025-01-15 | — | — | EP | disclosed |
| EP-4433457-A1 | HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME | Rgenta Therapeutics, Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-4433468-A1 | COMPOSITIONS AND METHODS FOR PRESERVING AND/OR RESTORING NEURAL FUNCTION | The Regents of the University of California (US) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023092098-A1 | HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME | RGENTA THERAPEUTICS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023086603-A1 | COMPOSITIONS AND METHODS FOR PRESERVING AND/OR RESTORING NEURAL FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-05-19 | — | — | WO | disclosed |
| US-11639346-B2 | Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS | ARAXES PHARMA LLC (US) | 2023-05-02 | — | — | US | disclosed |
| CN-114213243-A | Production system and method of sec-butyl acetate | 王义成 | 2022-03-22 | — | — | CN | disclosed |
| US-5650508-A | INHIBITORS OF SERINE AND CYSTEINE PROTEASES | GEORGIA TECH RESEARCH CORPORATION (US) | 1997-07-22 | — | — | US | disclosed |
| WO-1994006453-A1 | BRADYKININ ANTAGONISTS CONTAINING ALIPHATIC AMINO ACIDS IN THE 5-POSITION | STEWART JOHN M (US) | 1994-03-31 | — | — | WO | disclosed |